CLINICAL_TRIALS
trial_result
· 2022-03-29
Clinical Trial Update: Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants [Phase 2]
Summary
Phase 2 trial update on SAR440340 combined with dupilumab in moderate-to-severe asthma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2022-03-29